Get startedLog in
    Picture of Unicycive Therapeutics logo

    UNCY — Unicycive Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSmall Cap
    All News

    Brief: Unicycive Reports Key Findings Of Uni-494 Efficacy In Preclinical Animal Model Of Geographic Atrophy

    Picture of Unicycive Therapeutics logoUnicycive Therapeutics
    21/11/2022 12:05
    Nov 21 (Reuters) - Unicycive Therapeutics Inc  UNCY.O :
    * UNICYCIVE REPORTS KEY FINDINGS OF UNI-494 EFFICACY IN
PRECLINICAL ANIMAL MODEL OF GEOGRAPHIC ATROPHY
    * UNICYCIVE THERAPEUTICS INC - TREATMENT WITH UNI-494
IMPROVED
CONTRAST VISION IN ANIMAL MODELS OF GEOGRAPHIC ATROPHY (GA)
    * UNICYCIVE THERAPEUTICS INC - CO REMAINS ON TRACK TO
INITIATE A
PHASE I STUDY IN HEALTHY VOLUNTEERS DURING Q1 OF 2023 IN UK

Source text for Eikon:  ID:nGNX1Z5zs2 
Further company coverage:  UNCY.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Unicycive Therapeutics

    See all news